Supporting the Royal Marsden Cancer Charity

This year Trinity Homecare is supporting the Royal Marsden Cancer Charity through Le Cure.

Le Cure de France is a cycling event, set up to raise money for breast cancer research. The team – Les Curistas – have raised over £1.3 million which have directly funded research fellowships at the hospital.

In its sixth year, around 70 riders will take in more of the iconic Tour de France climbs over four days of riding in the French Alps. In four grueling days riders will tackle famous climbs  including Les Arcs, Col du Telegraphe, Col du Galibier and Alpe d’Huez.

This year Trinity Homecare’s managing director, Mike Smith will be participating in the ride taking place from 28th August to 31st August 2019.

“I know that most of us have been affected by cancer either directly or indirectly at some stage in our lives and I am delighted to be able to support Royal Marsden’s Cancer Charity. This year’s ride contains 12,361 meters of vertical gain which by my calculation is about 100 times the height gain of Box Hill so I hope you will sponsor me to reach our target for this year.”

Sponsor Mike

Curistas raise over £1.3 million

Les Curistas – Raising Money for Breast Cancer

How Le Cure began

In September 2013, Marianne was diagnosed with breast cancer. She was referred to The Royal Marsden where she was given chemotherapy and two drugs, herceptin and pertuzumab.

She was the first person at the hospital to receive this combination of drugs for a first occurrence of breast cancer. They were only available as part of a research programme run by Professor Ian Smith.

Just six months after her diagnosis, Marianne was given the all-clear. She wanted to do something to help more women like her benefit from our work, and Le Cure de France was born.

Funding for fellowships

The money raised by Le Cure has gone directly towards funding research fellowships at The Royal Marsden.

One published trial has already discovered that a blood test, or ‘liquid biopsy’, which picks up low levels of cancer DNA in the blood, can spot women who don’t respond that well to current hormonal treatments and would be better off being treated with newer drugs.

Other research funded by Le Cure includes developing a mechanism to detect cancers that will become resistant to treatment, and identifying whether DNA in blood following surgery can predict if the cancer will return. The results could help change the way we treat breast cancer worldwide.

Help us support Royal Marden to find the best treatments for breast cancer

Carrying out clinical trials or research into breast cancer would not be possible without supporters like you.

Sponsor Mike for the Le Cure 2019 to raise funds for The Royal Marsden Cancer Charity

Find out more about Le Cure

Find out more about the Royal Mardsen Cancer Charity